Related Experiment Videos
Cytotoxic effects of quinoxaline derivatives on human cancer cell lines
1Division of Medicinal Chemistry, College of Pharmacy, Ewha Womans University, Seoul, Korea.
Abstract:
The cytotoxicities of 6,7-modified-5,8-quinoxalinedione derivatives and heterocyclic quinoxaline derivatives containing nitrogen, sulfur, and oxygen on human lung adenocarcinoma cell (PC 14), human gastric adenocarcinoma cell (MKN 45), and human colon adenocarcinoma cell (colon 205) were examined in vitro using MTT assay. Pyrido[1,2-a]imidazo[4,5-g]quinoxaline-6,11-dione (10) was markedly cytotoxic against MKN 45 compared with adriamycin and cis-platin used as anticancer drugs. The IC50 value of compound 10 was 0.073 microM while those of adriamycin and cis-platin were 0.12 microM and 2.67 microM, respectively.
Insights
Researchers investigated novel quinoxaline derivatives for anticancer properties. Compound 10 showed significant cytotoxicity against gastric cancer cells (MKN 45), outperforming adriamycin and cisplatin.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Biology
Background:
- Quinoxaline derivatives are explored for their diverse biological activities.
- Developing novel anticancer agents with improved efficacy is a critical need.
- Cytotoxicity of heterocyclic compounds against various cancer cell lines is under investigation.
Purpose of the Study:
- To synthesize and evaluate the in vitro cytotoxicities of novel 6,7-modified-5,8-quinoxalinedione and heterocyclic quinoxaline derivatives.
- To compare the efficacy of a lead compound against human lung (PC 14), gastric (MKN 45), and colon (colon 205) adenocarcinoma cells.
- To assess the potential of these compounds as anticancer therapeutics.
Main Methods:
- Synthesis of quinoxaline derivatives containing nitrogen, sulfur, and oxygen.
- In vitro cytotoxicity assessment using the MTT assay.
- Determination of half-maximal inhibitory concentration (IC50) values for lead compounds and standard drugs.
Main Results:
- Pyrido[1,2-a]imidazo[4,5-g]quinoxaline-6,11-dione (compound 10) exhibited potent cytotoxicity against human gastric adenocarcinoma cells (MKN 45).
- Compound 10 demonstrated superior cytotoxicity compared to adriamycin and cisplatin against MKN 45 cells.
- The IC50 value for compound 10 was 0.073 µM, significantly lower than adriamycin (0.12 µM) and cisplatin (2.67 µM).
Conclusions:
- Novel quinoxaline derivatives possess significant cytotoxic potential against human adenocarcinoma cell lines.
- Compound 10 represents a promising candidate for further development as an anticancer agent, particularly for gastric cancer.
- The study highlights the therapeutic promise of heterocyclic quinoxaline scaffolds in oncology drug discovery.